Tumour suppressor activity of histone H1 in experimental mammary carcinoma

Indian Journal of Pharmacology

Volumn 32, Issue 3, 2000, Pages 210-213

  Vani, G ^a   Shyamala Devi, C S ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

CEA; Cytotoxicity; Histone H1; Histones; Tumour marker

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; HISTONE; HISTONE H1; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CANCER REGRESSION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG INHIBITION; FEMALE; NONHUMAN; RAT; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 0033936856     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Henderson IC, Canellos GP. Medical progress: Cancer of breast. The present decade. N Engl J Med 1980;320:17-30.
2. Bonadonna G, Valgussa P. Adjuvant systemic therapy for resectable breast cancer. J Clin Oncol 1985;3:259-69.
3. Legha SS, Buzdar AU, Smith IL et al. Complete remission in metastatic cancer treatment with combination drug therapy. Ann Intern Med 1979;91:847-52.
4. Mandelli F, Avvisati G, Amadori S, Boccadoro M, Gernone A et al. Maintenance treatment with recombinant interferon alpha 2b in patients with multiple myeloma responders to conventional induction chemotherapy. N Engl J Med 1990;322:1430-5.
5. Reiner Class, Lindman S, Fassbender C, Hans -Peter Leinen bach, Rawer S et al. Histone H1 suppresses tumor growth of leukemia cells in vitro, ex vivo and in an animal model suggesting extracellular functions of histones. Am J Clin Oncol 1996;19:522-31.
6. Levine AS, Nesbit ME, White JG, Yabro JW. Effects of fractionated histones on nucleic acid synthesis in 6C3HED mouse ascites tumor cells and normal spleen cells. Can Res 1968;28:831-44.
7. Latner AL, Turner GA, Longstaff E. Thymus histone treated BHK21 cells; malignant characteristics in vitro but reduced tumorigenicity. Europ J Cancer 1974;10:601-9.
8. Kolodny GM. Histone mediated changes in morphology and confluent density of cultured cells. J Cell Physiol 1973; 81:233-40.
9. Svironovsky AI, Levin VI, Shimanskaya TV, Nikolaichick VV, Zagorskeya LS. The influence of RNA and histone preparation on some properties of lymphoid cells. Tsitologia 1979;21:1337-41.
10. Elferink JGR. Cytolytic effect of polylysine on rabbit polymorphonuclear leukocytes. Inflammation 1985;9:321-31.
11. Becker FF, Green H. Effect of protamines and histones on the nucleic acids of ascites tumor cells. Exp Cell Res 1960; 19:361-75.
12. Zeppezauer M, Reichhart R. Use of pure histone H1 and H2A:H2B dimer in therapeutic methods. US Patent 1989; 5:218-57.
13. Quinton PM, Philpott CW. A role of anionic sites in epithelial architecture. J Cell Biol 1973;56:787-96.
14. Gatica M, Allende CC, Antonelli M, Allende JE. Polylysine containing peptides including the carboxy terminal augment of human C Ki ras 2 protein affect the activity of some key membrane enzymes. Proc Natl Acad Sci USA 1987; 84:324-8.
15. Rogers GT. Carcino embryonic antigen and related glycoprotein. Molecular aspects and specificty. Biochim Biophys Acta 1985;695:227-49.
16. John EW. Studies on histones. Preparative methods for histone fractionation from calf thymus. Biochem J 1964; 92:55-9.
17. Arun B, Udayachander M, Meenakshi A. 7,12-Dimethyl benz (a) anthracene induced mammary tumors in Wistar rats by "Air Pouch" technique- a new approach. Cancer Letter 1984;25:187-94.
18. Abeyounis CJ, Milgram F. Studies on carcino embryonic antigen. Int Arch Allergy Appl Immunol 1972;43:30-9.
19. Lowry OH, Rosebrough HJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951;193:262-75.
20. Cui S, Reicher JS, Mateo RB, Albina JE. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide dependent or independent mechanisms. Can Res 1994;54:2462-7.
21. Hiemstra PS, Eisenhauen PB, Harwig SS, Vander Barselaar MT, Van Furth et al. Antimicrobial proteins of murine macrophages. Infect Immunity 1993;61:3038-46.
22. Wang DY, Dulbrook RD, Hayward JL, Hendrick JC, Franchimont P. Relationship between plasma CEA and prognosis in women in breast cancer. Europ J Cancer 1975;11:615-25.
23. Tosmey DC, Waalkes TP, Ahmann D. Biological marker in breast carcinoma. Incidence of abnormalities of CEA, hCG, three polyamines and three minor nucleosides. Cancer 1975;35:1095-2000.
24. Shamberger RJ. Lysosomal enzyme changes in growing and regressing mammary tumors. Biochem J 1969;111: 375-83.